We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$22.8M
Cap. Flow
+$19.2K
Cap. Flow %
0%
Top 10 Hldgs %
21.31%
Holding
323
New
6
Increased
83
Reduced
132
Closed
14

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.34M
2
NVDA icon
NVIDIA
NVDA
+$2.14M
3
GILD icon
Gilead Sciences
GILD
+$1.94M
4
PRGO icon
Perrigo
PRGO
+$1.36M
5
BF.B icon
Brown-Forman Class B
BF.B
+$860K

Sector Composition

Rank Sector Weight
1 Technology 14.62%
2 Consumer Staples 13.11%
3 Healthcare 13.03%
4 Financials 12.76%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UN
151
DELISTED
Unilever NV New York Registry Shares
UN
$1.15M 0.09%
20,844
-300
-1% -$16.2K
ADP icon
152
Automatic Data Processing
ADP
$102B
$1.15M 0.09%
11,204
+57
+0.5% +$5.77K
VEA icon
153
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.14M 0.09%
27,588
+8,649
+46% +$353K
IWP icon
154
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$1.13M 0.09%
20,934
CL icon
155
Colgate-Palmolive
CL
$74.4B
$1.13M 0.09%
15,206
-400
-3% -$29.7K
GSIE icon
156
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.87B
$1.11M 0.09%
+40,204
New +$1.1M
TEVA icon
157
Teva Pharmaceuticals
TEVA
$37.3B
$1.11M 0.09%
33,491
-17,143
-34% -$531K
BCR
158
DELISTED
CR Bard Inc.
BCR
$1.1M 0.09%
3,490
AXP icon
159
American Express
AXP
$242B
$1.1M 0.09%
13,058
+200
+2% +$15.8K
AMGN icon
160
Amgen
AMGN
$198B
$1.06M 0.08%
6,137
+25
+0.4% +$4.07K
NKE icon
161
Nike
NKE
$64.9B
$1.05M 0.08%
17,846
-227
-1% -$12.2K
ITOT icon
162
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$1.05M 0.08%
18,966
CLX icon
163
Clorox
CLX
$11.6B
$1.02M 0.08%
7,674
-264
-3% -$35.6K
COST icon
164
Costco
COST
$417B
$1.01M 0.08%
6,322
-420
-6% -$72.4K
APD icon
165
Air Products & Chemicals
APD
$65.8B
$1M 0.08%
7,025
IVE icon
166
iShares S&P 500 Value ETF
IVE
$48.8B
$970K 0.08%
9,240
DVY icon
167
iShares Select Dividend ETF
DVY
$23.8B
$957K 0.07%
10,374
-500
-5% -$46K
DUK icon
168
Duke Energy
DUK
$97.5B
$928K 0.07%
11,100
-55
-0.5% -$4.62K
WDAY icon
169
Workday
WDAY
$35.8B
$918K 0.07%
9,461
AFL icon
170
Aflac
AFL
$63.5B
$914K 0.07%
23,526
IGSB icon
171
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$892K 0.07%
16,944
+388
+2% +$20.4K
OXY icon
172
Occidental Petroleum
OXY
$54.6B
$889K 0.07%
14,859
-11,510
-44% -$705K
SUB icon
173
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$884K 0.07%
8,356
EW icon
174
Edwards Lifesciences
EW
$49.4B
$876K 0.07%
22,227
VAR
175
DELISTED
Varian Medical Systems, Inc.
VAR
$858K 0.07%
8,317

Similar funds

Glenview Trust's Q2 2017 Portfolio in Review

As of Q2 2017, Glenview Trust held 323 positions worth $1.29B, up 1.8% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glenview Trust's Q2 2017 filing shows 6 new, 83 increased, 132 reduced and 14 closed positions. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 116,167 shares worth $5.59M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.34M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Glenview Trust's largest Q2 2017 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 116,167 shares worth $5.59M.
  • Glenview Trust added most to Danaher in Q2 2017, an estimated $3.36M increase.
  • Glenview Trust's biggest Q2 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.34M.
  • Glenview Trust fully exited iShares iBonds Dec 2017 Term Corporate ETF in Q2 2017, selling an estimated $417K.
  • Glenview Trust's ten largest holdings make up 21% of its $1.29B portfolio in Q2 2017.
  • Glenview Trust opened 6 new positions and closed 14 in Q2 2017.
  • Glenview Trust's portfolio value rose 1.8% quarter-over-quarter to $1.29B.

Based on Glenview Trust's 13F filing for Q2 2017, filed 11 Aug 2017.